Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Stewart Mearns MPS[/caption]
Reducing stroke risk in dementia patients
A commonly-used treatment for Alzheimer's disease could reduce the risk of stroke among people with dementia.
The Australian-Swedish study, co-authored by Monash University researchers, focussed...
Indirect impacts of COVID-19
Australia has had relative success in suppressing the COVID-19 virus, but there continues to be myriad ongoing and wide ranging indirect impacts.
Hepatitis C deaths fall sharply but cure access dropping
The introduction of direct-acting antivirals therapies for hepatitis C in 2016 has contributed to a 20% decline in deaths attributed to the disease, but...
Navigating South Pacific health care on a sea of data
A group of Melbourne pharmacists have developed a data aggregation and visualisation platform used for strengthening health supply chains, disaster response and improving health...
My Health Record – where to from here?
While the My Health Record (MHR) opt-out date of January 31 has come and gone, people still have the option to permanently delete their...
PSA’s critical role in 7CPA in spotlight
Federal Health Minister Greg Hunt has asserted the critical role that PSA will play in drafting the 7th Community Pharmacy Agreement (CPA), shaping the...
